Ann: Full Year Statutory Accounts and Appendix 4E, page-4

First 4 Last

Share
Profile

Follow
daz1982

2,622 Posts.

57

21/11/17

18:18

Post #: 28994888
Share

Originally posted by firsova ↑

The market cap at 4 cents is just over $10 million so its hard to call the stock expensive.

4 cents per share is a market cap of less than 25% of revenue

All the financial indicators are improving after a few years of decline , so its surprising the see the stock struggling to break that 4 cents level now they have reported positive momentum and making sales in IK , China, Dubai , NZ and Australia .

I really think there is a lot of stale shareholders holding it back , there was a lot of shareholders about 4 years ago that paid 8 cents and they caused a lot of trouble

I think the worst is over and a lot of upside if in reading the annual report of a strong order book is forthcoming and we see electric and driver less cars replace the current vehicles on the road then quality road lighting is going to be critical for our government to create its implementation .

The positive for 16./17 was the EBIT was up 114% for 2016/17 to $2.679m the negative was the EBIT was only 6% of revenue, so a 94% expense to EBIT .

The good news though was that they reported they have started 17/18 strongly with strong order book, and this gives me confidence they can move towards $70m of revenue and then try get the EBIT margin on higher sales levels towards 10% which is where companies trading on multiples of 12 times EBIT are trading at.

With less than 300m shares on issue a $7m EBIT should start to see a much higher market cap

Expand

Still in this stock?

TTI Price at posting: 3.9¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

OJC

SPC to merge with Original Juice Co and Nature One Dairy

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

First 4 Last

Add TTI (ASX) to my watchlist

(20min delay)
Last 0.4¢		Change 0.001(33.3%)		Mkt cap ! $3.891M

Open	High	Low	Value	Volume
0.3¢	0.4¢	0.3¢	$431	108.7K

Buyers (Bids)

No.	Vol.	Price($)
13	8090036	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	1897228	1

View Market Depth

No.	Vol.	Price($)
13	8090036	0.003
6	2500000	0.002
3	3800999	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	1897228	1
0.005	1118120	5
0.006	1300000	2
0.007	100000	1
0.008	327000	3

Last trade - 15.58pm 02/10/2024 (20 minute delay)

TTI (ASX) Chart

Ann: Full Year Statutory Accounts and Appendix 4E, page-4

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Full Year Statutory Accounts and Appendix 4E, page-4

Top Stories

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News